Le Thieu, Minh Khai
Homayouni, Amin
Hæren, Lena Ringsby
Tiainen, Hanna
Verket, Anders
Ellingsen, Jan Eirik
Rønold, Hans Jacob
Wohlfahrt, Johan Caspar
Cantalapiedra, Antonio Gonzalez
Muñoz, Fernando Maria Guzon
Mendaña, Maria Permuy
Lyngstadaas, Ståle Petter
Haugen, Håvard Jostein http://orcid.org/0000-0002-6690-7233
Funding for this research was provided by:
norges forskningsråd (228415)
dentsply implants (I-AS-14-009)
Article History
Received: 29 June 2021
Accepted: 15 November 2021
First Online: 25 November 2021
Declarations
:
: The Regional Ethics Committee for Animal Research of the University of Santiago de Compostela approved the protocol (Ref. AE-LU-001/002/14).
: Not applicable.
: Haugen, Ellingsen, Tiainen and Lyngstadaas are inventors of the technology behind the production of TiO<sub>2</sub> scaffold (WO2014044672, WO2008078164). The commercial rights for the TiO<sub>2</sub> scaffold belongs to Corticalis AS. Haugen, Ellingsen, Lyngstadaas, Rønold and Wohlfahrt are shareholder of Corticalis AS.